- Previous Close
2,345.85 - Open
2,345.55 - Bid --
- Ask --
- Day's Range
2,223.50 - 2,358.90 - 52 Week Range
1,292.85 - 3,379.00 - Volume
4,817 - Avg. Volume
5,085 - Market Cap (intraday)
18.935B - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
80.54 - EPS (TTM)
27.62 - Earnings Date Jan 31, 2025 - Feb 4, 2025
- Forward Dividend & Yield 6.00 (0.26%)
- Ex-Dividend Date Aug 22, 2024
- 1y Target Est
--
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucella abortus, contagious bovine pleuropneumonia, CCPP, and lumpy skin diseases; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutic treatment, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides seroprofiling kits; diagnostic labs for poultry flocks; and mastitis control programs for cattle; as well as engages in manufacturing and trading of goods. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.
www.hester.in642
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: HESTERBIO.NS
View MorePerformance Overview: HESTERBIO.NS
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HESTERBIO.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HESTERBIO.NS
View MoreValuation Measures
Market Cap
19.27B
Enterprise Value
21.36B
Trailing P/E
82.07
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.17
Price/Book (mrq)
6.38
Enterprise Value/Revenue
6.84
Enterprise Value/EBITDA
33.41
Financial Highlights
Profitability and Income Statement
Profit Margin
7.42%
Return on Assets (ttm)
4.74%
Return on Equity (ttm)
8.68%
Revenue (ttm)
3.16B
Net Income Avi to Common (ttm)
234.69M
Diluted EPS (ttm)
27.62
Balance Sheet and Cash Flow
Total Cash (mrq)
167.88M
Total Debt/Equity (mrq)
77.65%
Levered Free Cash Flow (ttm)
252.18M